title: Low-dose oral pimobendan emancipates patients with severe ischemic pump failure from intravenous catecholamine infusion for cardiogenic shock.
authors.affiliation: Department of Cardiology, National Hospital Organization, Mito Medical Center, Japan. Electronic address: tomomikzm2014@gmail.com.
authors.forename: Tomomi
authors.initials: T
authors.lastname: Koizumi
authors.affiliation: Department of Cardiology, National Hospital Organization, Mito Medical Center, Japan.
authors.forename: Shuichi
authors.initials: S
authors.lastname: Taguchi
mesh_terms: D000284:Administration, Oral; D000369:Aged, 80 and over; D002316:Cardiotonic Agents / Q000008:administration & dosage; D002395:Catecholamines / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D011724:Pyridazines / Q000008:administration & dosage*; D012720:Severity of Illness Index; D012770:Shock, Cardiogenic / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D002316:Cardiotonic Agents; D002395:Catecholamines; D011724:Pyridazines; C041648:pimobendan
keywords: Cardiogenic shock; Ischemic heart disease; Low-dose pimobendan